Research Articles | Page 11 | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journalsort ascending Bone Marrow Disease
Polymorphisms of Interlukin-1β rs16944 confer susceptibility to myelodysplastic syndromes Nov 2016 Life Sci. myelodysplastic syndromes (MDS)
Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia-a wise Liaison? May 2013 Leukemia myelodysplastic syndromes (MDS)
Prevalence of somatic mutations in patients with aplastic anemia using peripheral blood cfDNA As compared with BM Aug 2017 Leukemia aplastic anemia
Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry Sep 2015 Leukemia myelodysplastic syndromes (MDS)
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes Mar 2015 Leukemia myelodysplastic syndromes (MDS)
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes Aug 2017 Leukemia
Application of the International Prognostic Scoring System-Revised (IPSS-R) in Therapy-related Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia. Jun 2013 Leukemia myelodysplastic syndromes (MDS)
Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study Jan 2013 Leukemia myelodysplastic syndromes (MDS)
Expression of nucleoside metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine Nov 2013 Leukemia myelodysplastic syndromes (MDS)
Distinct iron architecture in SF3B1 mutant myelodysplastic syndromes patients is linked to an SLC25A37 splice variant with a retained intron May 2014 Leukemia myelodysplastic syndromes (MDS)